Transient elastography: should XL probe be used in all overweight patients?
- 19 July 2019
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 54 (8) , 1022-1026
Abstract
Background: Obesity is one of the main factors of transient elastography (TE) failure, considering body mass index (BMI) ≥28 kg/m2 as a limiting factor. The XL probe was designed to overcome this limitation. Aim: To compare the feasibility of the M and XL probes in patients with BMI ≥ 28 kg/m2, to evaluate differences in mean values of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) between the two probes and find predictive factors of TE failure. Material and methods: Prospective study, including all patients with BMI ≥ 28 kg/m2 consecutively admitted for TE. Results: Included 161 patients. Measurements with M probe were reliable in 69.6% of the patients, with 68.2% of valid measurements in obese population and 58.9% in patients with skin-capsule distance (SCD) >25 mm. In 40 patients (81.6%) with an invalid M probe measurement, a reliable result was obtained with XL probe. We found that SCD >25 mm was the only predictor of M probe failure (OR: 4.9, CI: 1.64–14.63, p = .004). In those patients in which TE was possible with both probes (n = 112), mean CAP was 304 ± 49 dB/m2 with M probe and 301 ± 50 dB/m2 with XL probe (p = .59). Regarding liver stiffness, a mean value of 7.58 ± 3.47 kpas was obtained with the M probe and 6.21 ± 3.44 kpas with the XL probe (p < .001). Conclusion: There is a reliable applicability of the M probe in a high number (68.2%) of patients with a BMI ≥30 kg/m2. A SCD >25 mm was the only predictive factor of M probe failure. Mean values of LSM with XL probe were lower than those obtained with M probe.Keywords
This publication has 31 references indexed in Scilit:
- Liver disease in the morbidly obese: a review of 1000 consecutive patients undergoing weight loss surgerySurgery for Obesity and Related Diseases, 2015
- Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The GambiaAlimentary Pharmacology & Therapeutics, 2013
- Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastographyLiver International, 2012
- Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probeJournal of Hepatology, 2012
- Feasibility and Diagnostic Performance of the Fibroscan XL Probe for Liver Stiffness Measurement in Overweight and Obese PatientsHepatology, 2011
- Feasibility of liver transient elastography with FibroScan® using a new probe for obese patientsLiver International, 2010
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical ImplicationsHepatology, 2010
- Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infectionLiver International, 2009
- Liver biopsy†Hepatology, 2009
- Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinationsEuropean Journal of Gastroenterology & Hepatology, 2006